Company intelligence / Profile preview

Navinta LLC

Ewing, New Jersey, United Statesnavinta.com ↗

Ownership: Private
Employees: ~36
Development stage: Commercial

Overview

Navinta has a portfolio of at least seventeen approved drugs in the U.S., with expertise in complex generics and novel formulations. The company holds over twenty process/product patents and maintains an active pipeline focused on oral dosage forms, injectables, sprays, and APIs. Their regulatory strategy includes both ANDA filings for generics and NDA submissions for differentiated products. They have a DEA registered facility for controlled substances manufacturing.

Therapeutic areas: OtherRare Diseases
Modalities: Small molecules (oral tablets, capsules)Injectables (solutions, lyophilized)Sprays (novel delivery systems)APIs (active pharmaceutical ingredients)
Industry: Biotech

Drug pipeline

3 assets

ropivacaine

Commercial

Indications: Pain

2 more assets in the full pipeline.

Partnerships

External partnerships with FDA/MHRA-approved contract manufacturers for production/distribution; specific partners not named.

Beyond the preview

Go deeper on Navinta LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navinta LLC.